Pages that link to "Q22010733"
Jump to navigation
Jump to search
The following pages link to Cystatin C deficiency in human atherosclerosis and aortic aneurysms (Q22010733):
Displaying 50 items.
- Cystatin C (Q413243) (← links)
- CST3 (Q14913588) (← links)
- Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases (Q24673558) (← links)
- Importance of lysosomal cysteine proteases in lung disease (Q24791513) (← links)
- The autophagy-lysosomal system in subarachnoid haemorrhage (Q26749374) (← links)
- The lysosome: from waste bag to potential therapeutic target (Q27022248) (← links)
- Current perspectives on Kawasaki disease (Q28185961) (← links)
- Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms (Q28202574) (← links)
- Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients? (Q28534470) (← links)
- Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells (Q28564439) (← links)
- Presence of anti-cystatin C-positive dendritic cells or macrophages and localization of cysteine proteases in the apical bud of the enamel organ in the rat incisor (Q28569427) (← links)
- Cystatin 10, a novel chondrocyte-specific protein, may promote the last steps of the chondrocyte differentiation pathway (Q28587838) (← links)
- Cystatin C and Cardiovascular Disease: A Mendelian Randomization Study (Q30276065) (← links)
- Arterial indices and serum cystatin C level in individuals with occupational wide band noise exposure. (Q30364243) (← links)
- Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice (Q30528440) (← links)
- Nuclear Factor kappa B is central to Marek's disease herpesvirus induced neoplastic transformation of CD30 expressing lymphocytes in-vivo (Q31090571) (← links)
- Gene expression profiling of resting and activated vascular smooth muscle cells by serial analysis of gene expression and clustering analysis (Q31152985) (← links)
- Systematic optimization of multiplex zymography protocol to detect active cathepsins K, L, S, and V in healthy and diseased tissue: compromise among limits of detection, reduced time, and resources (Q33439543) (← links)
- Innate and adaptive immunity in atherosclerosis (Q33659705) (← links)
- Regulation of TGF-β1-driven differentiation of human lung fibroblasts: emerging roles of cathepsin B and cystatin C. (Q33718504) (← links)
- Who are the proteolytic culprits in vascular disease? (Q33764359) (← links)
- Increased serum cathepsin K in patients with coronary artery disease (Q33822554) (← links)
- Relationship between cystatin C and coronary artery atherosclerosis progression differs by type 1 diabetes (Q33905277) (← links)
- Hereditary cystatin C amyloid angiopathy (Q33937075) (← links)
- Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice (Q33947334) (← links)
- Significant proteins affecting cerebral vasospasm using complementary ICPMS and MALDI-MS. (Q34041312) (← links)
- Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation (Q34062726) (← links)
- The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies (Q34107537) (← links)
- Influence of a prudent diet on circulating cathepsin S in humans (Q34136197) (← links)
- Vascular smooth muscle cell peroxisome proliferator-activated receptor-γ deletion promotes abdominal aortic aneurysms (Q34172757) (← links)
- Biochemistry and clinical role of human cystatin C. (Q34377103) (← links)
- Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. (Q34458717) (← links)
- Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications (Q34476390) (← links)
- Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse (Q34550560) (← links)
- Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice (Q34674607) (← links)
- Novel aspects of the pathogenesis of aneurysms of the abdominal aorta in humans (Q34682737) (← links)
- Genes and abdominal aortic aneurysm (Q34683905) (← links)
- Olive flounder (Paralichthys olivaceus) cystatin C: cloning, mRNA expression, and enzymatic characterization of olive flounder cystatin C. (Q34708062) (← links)
- Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice (Q34967612) (← links)
- Higher cystatin C level predicts long-term mortality in patients with peripheral arterial disease. (Q35032801) (← links)
- Salivary (SD-type) cystatins: over one billion years in the making--but to what purpose? (Q35033473) (← links)
- Proteinases and their inhibitors in the immune system (Q35035050) (← links)
- Mechanisms of plaque vulnerability and rupture (Q35088065) (← links)
- Cysteinyl cathepsins and mast cell proteases in the pathogenesis and therapeutics of cardiovascular diseases (Q35098737) (← links)
- Pathophysiology of plaque rupture and the concept of plaque stabilization (Q35585929) (← links)
- Cathepsin K Deficiency Reduces Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice (Q35592574) (← links)
- Expansive arterial remodeling: location, location, location. (Q35649492) (← links)
- 6. Cathepsin K inhibitors: their potential as anti-osteoporosis agents (Q35683586) (← links)
- Cathepsin L activity is essential to elastase perfusion-induced abdominal aortic aneurysms in mice (Q35851900) (← links)
- Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm (Q35883165) (← links)